AbbVie, Inc. (ABBV)
AbbVie Market Cap: 380.45B for Jan. 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 182.45B |
| Biogen, Inc. | 25.02B |
| Gilead Sciences, Inc. | 157.75B |
| Johnson & Johnson | 522.00B |
| Eli Lilly & Co. | 962.60B |
Market Cap Related Metrics
| PE Ratio | 162.42 |
| PS Ratio | 6.392 |
| Price to Free Cash Flow | 19.37 |
| Price | 215.26 |
| Earnings Yield | 0.62% |
| Operating PE Ratio | 20.01 |
| Normalized PE Ratio | 28.93 |